FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067167584> ?p ?o ?g. }

• W2067167584 endingPage "394" @default.
• W2067167584 startingPage "383" @default.
• W2067167584 abstract "Autoimmune myositis encompasses various myositis-overlap syndromes, each being identified by the presence of serum marker autoantibodies. We describe a novel myositis-overlap syndrome in 4 patients characterized by the presence of a unique immunologic marker, autoantibodies to nuclear pore complexes. The clinical phenotype was characterized by prominent myositis in association with erosive, anti-CCP, and rheumatoid factor-positive arthritis, trigeminal neuralgia, mild interstitial lung disease, Raynaud phenomenon, and weight loss. The myositis was typically chronic, relapsing, and refractory to corticosteroids alone, but remitted with the addition of a second immunomodulating drug. There was no clinical or laboratory evidence for liver disease. The prognosis was good with 100% long-term survival (mean follow-up 19.5 yr). By indirect immunofluorescence on HEp-2 cells, sera from all 4 patients displayed a high titer of antinuclear autoantibodies (ANA) with a distinct punctate peripheral (rim) fluorescent pattern of the nuclear envelope characteristic of nuclear pore complexes. Reactivity with nuclear pore complexes was confirmed by immunoelectron microscopy. In a cohort of 100 French Canadian patients with autoimmune myositis, the nuclear pore complex fluorescent ANA pattern was restricted to these 4 patients (4%). It was not observed in sera from 393 adult patients with systemic sclerosis (n = 112), mixed connective tissue disease (n = 35), systemic lupus (n = 94), rheumatoid arthritis (n = 45), or other rheumatic diseases (n = 107), nor was it observed in 62 normal adults. Autoantibodies to nuclear pore complexes were predominantly of IgG isotype. No other IgG autoantibody markers for defined connective tissue diseases or overlap syndromes were present, indicating a selective and highly focused immune response. In 3 patients, anti-nuclear pore complex autoantibody titers varied in parallel with myositis activity, suggesting a pathogenic link to pathophysiology. The nuclear pore complex proteins, that is, nucleoporins (nup), recognized by these sera were heterogeneous and included Nup358/RanBP2 (n = 2 patients), Nup90 (n = 1), Nup62 (n = 1), and gp210 (n = 1). Taken together the data suggest that nup autoantigens themselves drive the anti-nup autoimmune response. Immunogenetically, the 4 patients shared the DQA1*0501 allele associated with an increased risk for autoimmune myositis. In conclusion, we report an apparent novel subset of autoimmune myositis in our population of French Canadian patients with connective tissue diseases. This syndrome is recognized by the presence of a unique immunologic marker, autoantibodies to nuclear pore complexes that react with nups, consistent with an “anti-nup syndrome.”" @default.
• W2067167584 created "2016-06-24" @default.
• W2067167584 creator A5011458972 @default.
• W2067167584 creator A5012249581 @default.
• W2067167584 creator A5019521944 @default.
• W2067167584 creator A5047753466 @default.
• W2067167584 creator A5049919211 @default.
• W2067167584 creator A5066655081 @default.
• W2067167584 creator A5087602901 @default.
• W2067167584 creator A5089248557 @default.
• W2067167584 creator A5089696743 @default.
• W2067167584 date "2014-11-01" @default.
• W2067167584 modified "2023-10-18" @default.
• W2067167584 title "An Autoimmune Myositis-Overlap Syndrome Associated With Autoantibodies to Nuclear Pore Complexes" @default.
• W2067167584 cites W1502860325 @default.
• W2067167584 cites W1528870087 @default.
• W2067167584 cites W1604050396 @default.
• W2067167584 cites W169147976 @default.
• W2067167584 cites W1963670734 @default.
• W2067167584 cites W1964495124 @default.
• W2067167584 cites W1964539908 @default.
• W2067167584 cites W1967721132 @default.
• W2067167584 cites W1968009907 @default.
• W2067167584 cites W1969081908 @default.
• W2067167584 cites W1971455565 @default.
• W2067167584 cites W1973552403 @default.
• W2067167584 cites W1986267357 @default.
• W2067167584 cites W1987695869 @default.
• W2067167584 cites W1995585759 @default.
• W2067167584 cites W1996842986 @default.
• W2067167584 cites W2016901949 @default.
• W2067167584 cites W2025155991 @default.
• W2067167584 cites W2031973282 @default.
• W2067167584 cites W2034457199 @default.
• W2067167584 cites W2034714335 @default.
• W2067167584 cites W2045032288 @default.
• W2067167584 cites W2045048491 @default.
• W2067167584 cites W2045930677 @default.
• W2067167584 cites W2047865546 @default.
• W2067167584 cites W2048592275 @default.
• W2067167584 cites W2049648707 @default.
• W2067167584 cites W2051302134 @default.
• W2067167584 cites W2054524227 @default.
• W2067167584 cites W2071163737 @default.
• W2067167584 cites W2084345825 @default.
• W2067167584 cites W2089255535 @default.
• W2067167584 cites W2090853807 @default.
• W2067167584 cites W2101398747 @default.
• W2067167584 cites W2103803573 @default.
• W2067167584 cites W2105897610 @default.
• W2067167584 cites W2107329641 @default.
• W2067167584 cites W2108710785 @default.
• W2067167584 cites W2119089691 @default.
• W2067167584 cites W2119938023 @default.
• W2067167584 cites W2126606015 @default.
• W2067167584 cites W2143367204 @default.
• W2067167584 cites W2145242726 @default.
• W2067167584 cites W2153894357 @default.
• W2067167584 cites W2167183423 @default.
• W2067167584 cites W2314311014 @default.
• W2067167584 cites W2321394641 @default.
• W2067167584 cites W4245451115 @default.
• W2067167584 cites W4313347700 @default.
• W2067167584 doi "https://doi.org/10.1097/md.0000000000000223" @default.
• W2067167584 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4602431" @default.
• W2067167584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25500708" @default.
• W2067167584 hasPublicationYear "2014" @default.
• W2067167584 type Work @default.
• W2067167584 sameAs 2067167584 @default.
• W2067167584 citedByCount "11" @default.
• W2067167584 countsByYear W20671675842015 @default.
• W2067167584 countsByYear W20671675842017 @default.
• W2067167584 countsByYear W20671675842018 @default.
• W2067167584 countsByYear W20671675842019 @default.
• W2067167584 countsByYear W20671675842021 @default.
• W2067167584 countsByYear W20671675842022 @default.
• W2067167584 countsByYear W20671675842023 @default.
• W2067167584 crossrefType "journal-article" @default.
• W2067167584 hasAuthorship W2067167584A5011458972 @default.
• W2067167584 hasAuthorship W2067167584A5012249581 @default.
• W2067167584 hasAuthorship W2067167584A5019521944 @default.
• W2067167584 hasAuthorship W2067167584A5047753466 @default.
• W2067167584 hasAuthorship W2067167584A5049919211 @default.
• W2067167584 hasAuthorship W2067167584A5066655081 @default.
• W2067167584 hasAuthorship W2067167584A5087602901 @default.
• W2067167584 hasAuthorship W2067167584A5089248557 @default.
• W2067167584 hasAuthorship W2067167584A5089696743 @default.
• W2067167584 hasBestOaLocation W20671675841 @default.
• W2067167584 hasConcept C142724271 @default.
• W2067167584 hasConcept C149443304 @default.
• W2067167584 hasConcept C159654299 @default.
• W2067167584 hasConcept C163764329 @default.
• W2067167584 hasConcept C203014093 @default.
• W2067167584 hasConcept C2775941666 @default.
• W2067167584 hasConcept C2776153627 @default.
• W2067167584 hasConcept C2776232647 @default.
• W2067167584 hasConcept C2776670291 @default.
• W2067167584 hasConcept C2777575956 @default.

• next